These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 28696232)
1. Community Composition Determines Activity of Antibiotics against Multispecies Biofilms. Tavernier S; Crabbé A; Hacioglu M; Stuer L; Henry S; Rigole P; Dhondt I; Coenye T Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696232 [TBL] [Abstract][Full Text] [Related]
2. Decreased susceptibility of Streptococcus anginosus to vancomycin in a multispecies biofilm is due to increased thickness of the cell wall. Tavernier S; Sass A; De Bruyne M; Baeke F; De Rycke R; Crabbé A; Vandecandelaere I; Van Nieuwerburgh F; Coenye T J Antimicrob Chemother; 2018 Sep; 73(9):2323-2330. PubMed ID: 29901811 [TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics. Orazi G; Ruoff KL; O'Toole GA mBio; 2019 Jul; 10(4):. PubMed ID: 31363032 [No Abstract] [Full Text] [Related]
5. A Pseudomonas aeruginosa Antimicrobial Affects the Biogeography but Not Fitness of Staphylococcus aureus during Coculture. Barraza JP; Whiteley M mBio; 2021 Mar; 12(2):. PubMed ID: 33785630 [No Abstract] [Full Text] [Related]
6. Pseudomonas aeruginosa PA14 Enhances the Efficacy of Norfloxacin against Staphylococcus aureus Newman Biofilms. Orazi G; Jean-Pierre F; O'Toole GA J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32661077 [TBL] [Abstract][Full Text] [Related]
7. Bacteriophages as potential antibiotic potentiators in cystic fibrosis: A new model to study the combination of antibiotics with a bacteriophage cocktail targeting dual species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. Wang Z; De Soir S; Glorieux A; Merabishvili M; Knoop C; De Vos D; Pirnay JP; Van Bambeke F Int J Antimicrob Agents; 2024 Sep; 64(3):107276. PubMed ID: 39009289 [TBL] [Abstract][Full Text] [Related]
8. Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms. Stewart EJ; Payne DE; Ma TM; VanEpps JS; Boles BR; Younger JG; Solomon MJ Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411222 [TBL] [Abstract][Full Text] [Related]
9. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System. Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523 [TBL] [Abstract][Full Text] [Related]
10. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model. Tré-Hardy M; Macé C; El Manssouri N; Vanderbist F; Traore H; Devleeschouwer MJ Int J Antimicrob Agents; 2009 Jan; 33(1):40-5. PubMed ID: 18801647 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility of cystic fibrosis lung microbiome members in a multispecies biofilm. Vandeplassche E; Sass A; Ostyn L; Burmølle M; Kragh KN; Bjarnsholt T; Coenye T; Crabbé A Biofilm; 2020 Dec; 2():100031. PubMed ID: 33447816 [TBL] [Abstract][Full Text] [Related]
12. Activity of disinfectants against multispecies biofilms formed by Staphylococcus aureus, Candida albicans and Pseudomonas aeruginosa. Kart D; Tavernier S; Van Acker H; Nelis HJ; Coenye T Biofouling; 2014; 30(3):377-83. PubMed ID: 24579656 [TBL] [Abstract][Full Text] [Related]
13. Influence of biofilm growth age, media, antibiotic concentration and exposure time on Staphylococcus aureus and Pseudomonas aeruginosa biofilm removal in vitro. Chen X; Thomsen TR; Winkler H; Xu Y BMC Microbiol; 2020 Aug; 20(1):264. PubMed ID: 32831025 [TBL] [Abstract][Full Text] [Related]
15. Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model. Rodríguez-Sevilla G; García-Coca M; Romera-García D; Aguilera-Correa JJ; Mahíllo-Fernández I; Esteban J; Pérez-Jorge C Int J Med Microbiol; 2018 Apr; 308(3):413-423. PubMed ID: 29555180 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory efficacy of various antibiotics on matrix and viable mass of Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Toté K; Berghe DV; Deschacht M; de Wit K; Maes L; Cos P Int J Antimicrob Agents; 2009 Jun; 33(6):525-31. PubMed ID: 19179053 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of biofilm formation by esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureus. Singh V; Arora V; Alam MJ; Garey KW Antimicrob Agents Chemother; 2012 Aug; 56(8):4360-4. PubMed ID: 22664967 [TBL] [Abstract][Full Text] [Related]
18. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor. Furiga A; Lajoie B; El Hage S; Baziard G; Roques C Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774 [TBL] [Abstract][Full Text] [Related]
19. Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung. Harrington NE; Sweeney E; Alav I; Allen F; Moat J; Harrison F J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554970 [TBL] [Abstract][Full Text] [Related]
20. D-amino acids enhance the activity of antimicrobials against biofilms of clinical wound isolates of Staphylococcus aureus and Pseudomonas aeruginosa. Sanchez CJ; Akers KS; Romano DR; Woodbury RL; Hardy SK; Murray CK; Wenke JC Antimicrob Agents Chemother; 2014 Aug; 58(8):4353-61. PubMed ID: 24841260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]